| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 11.02.
| Uptrend Call Working As ISTA Pharmaceuticals Stock Rises 93.6% | | - | SmarTrend |
| 09.02.
| ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2011 Financial Results | | 16 | MarketWire |
| IRVINE, CA -- (Marketwire) -- 02/09/12 -- ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced it will release fourth quarter and full-year 2011 financial results after market on February 23...
Mehr lesen zu:
ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2011 Financial Results | |
| 03.02.
| Uptrend Call Working As ISTA Pharmaceuticals Stock Rises 95.0% | | - | SmarTrend |
| 02.02.
| Relatively High Future Earnings Growth Detected in Shares of ISTA Pharmaceuticals in the Pharmaceuticals Industry | | - | SmarTrend |
| 01.02.
| Are ISTA Pharmaceuticals' Numbers Better Than They Look? | | - | Motley Fool |
| 30.01.
| ISTA Pharmaceuticals Falling Today on Above-Average Volume | | - | SmarTrend |
| 30.01.
| Highlights der US-Vorbörse: Amylin Pharma, ISTA Pharma, Thomas & Betts | | 21 | GodmodeTrader.de |
| 30.01.
| Valeant pulls bid for ISTA Pharmaceuticals | | 1 | Financial Post |
| 30.01.
| Valeant withdraws offer for ISTA Pharmaceuticals valued at US$7.50 per share | | 1 | Yahoo-CAN |
| 30.01.
| Valeant Pulls Ista Pharma Takeout Bid | | - | The Street |
| 30.01.
| Valeant Pharma scraps offer for ISTA Pharma | | 1 | MarketWatch |
| 30.01.
| Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals Inc. | | 90 | PR Newswire |
| MISSISSAUGA, Ontario, Jan. 30, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has withdrawn its offer to acquire ISTA Pharmaceuticals...
Mehr lesen zu:
Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals Inc. | |
| 30.01.
| ISTA Pharma (ISTA) Completes Enrollment in BEPOSON Phase 2 | | - | StreetInsider.com |
| 30.01.
| ISTA Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study of BEPOSONE(TM) (Bepotastine Besilate - Steroid Combination Nasal Spray) for the Treatment of Symptoms Associated With Seasonal Allergic Rhinitis | | 36 | MarketWire |
| IRVINE, CA -- (Marketwire) -- 01/30/12 -- ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), today announced it has successfully enrolled more than 600 patients in the Company's Phase 2 clinical study of...
Mehr lesen zu:
ISTA Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study of BEPOSONE(TM) (Bepotastine Besilate - Steroid Combination Nasal Spray) for the Treatment of Symptoms Associated With Seasonal Allergic Rhinitis | |
| 27.01.
| ISTA Pharmaceuticals Up 92.1% Since SmarTrend Uptrend Call | | - | SmarTrend |
| 18.01.
| UPDATE: Auriga Downgrades ISTA Pharmaceuticals to Hold, $9 PT | | - | Benzinga.com |
| 17.01.
| ISTA Pharma Surges after Valeant Ups Acquisition Price | | 4 | Benzinga.com |
| 17.01.
| ISTA Pharmaceuticals Rising Today on Above-Average Volume | | - | SmarTrend |
| 17.01.
| Shares of ISTA Pharmaceuticals Receive a Boost, Up 12.5% | | - | SmarTrend |
| 17.01.
| Valeant boosts bid for ISTA Pharmaceuticals to US$7.50 per share from $6.50 | | 2 | Yahoo-CAN |
